These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9727846)

  • 21. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
    Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
    Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study.
    Siemensma EP; van Alfen-van der Velden AA; Otten BJ; Laven JS; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1766-73. PubMed ID: 22723315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor (AR) gene CAG trinucleotide repeat length associated with body composition measures in non-syndromic obese, non-obese and Prader-Willi syndrome individuals.
    Butler MG; Manzardo AM
    J Assist Reprod Genet; 2015 Jun; 32(6):909-15. PubMed ID: 25925349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The growth hormone response to hexarelin in patients with Prader-Willi syndrome.
    Cappa M; Raguso G; Palmiotto T; Faedda A; Gurreri F; Neri G; Deghenghi R; Loche S
    J Endocrinol Invest; 1998 Sep; 21(8):501-5. PubMed ID: 9801990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database).
    Lindgren AC; Lindberg A
    Horm Res; 2008; 70(3):182-7. PubMed ID: 18663319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. References for growth and pubertal development from birth to 21 years in Flanders, Belgium.
    Roelants M; Hauspie R; Hoppenbrouwers K
    Ann Hum Biol; 2009; 36(6):680-94. PubMed ID: 19919503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade.
    Hirsch HJ; Eldar-Geva T; Bennaroch F; Pollak Y; Gross-Tsur V
    Hum Reprod; 2015 Nov; 30(11):2587-96. PubMed ID: 26345685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years].
    Li H; Ji CY; Zong XN; Zhang YQ
    Zhonghua Er Ke Za Zhi; 2009 Jul; 47(7):487-92. PubMed ID: 19951507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of growth hormone treatment on height, weight, and obesity in Taiwanese patients with Prader-Willi syndrome.
    Lin HY; Lin SP; Tsai LP; Chao MC; Chen MR; Chuang CK; Huang CY; Tsai FJ; Chou IC; Chiu PC; Huang CH; Yen JL; Lin JL; Kuo PL
    J Chin Med Assoc; 2008 Jun; 71(6):305-9. PubMed ID: 18567561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth charts for non-growth hormone treated Prader-Willi syndrome.
    Butler MG; Lee J; Manzardo AM; Gold JA; Miller JL; Kimonis V; Driscoll DJ
    Pediatrics; 2015 Jan; 135(1):e126-35. PubMed ID: 25489013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle-bone characteristics in children with Prader-Willi syndrome.
    Edouard T; Deal C; Van Vliet G; Gaulin N; Moreau A; Rauch F; Alos N
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E275-81. PubMed ID: 22162467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prader-Willi syndrome and chromosome 15. A clinical discussion of 20 cases.
    Mattei JF; Mattei MG; Giraud F
    Hum Genet; 1983; 64(4):356-62. PubMed ID: 6618488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
    Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
    Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-cultural comparisons of obesity and growth in Prader-Willi syndrome.
    Dudley O; McManus B; Vogels A; Whittington J; Muscatelli F
    J Intellect Disabil Res; 2008 May; 52(Pt 5):426-36. PubMed ID: 18298478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive team approach to the management of patients with Prader-Willi syndrome.
    Eiholzer U; Whitman BY
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1153-75. PubMed ID: 15506675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Children born small for gestational age (SGA) who fail to achieve catch up growth by 2-8 years of age are short from infancy to adulthood. Data from a cross-sectional study of 486 Spanish children.
    Carrascosa A; Vicens-Calvet E; Yeste D; Espadero RM; Ulied A;
    Pediatr Endocrinol Rev; 2006 Sep; 4(1):15-27. PubMed ID: 17021579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.